rs10509969

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001367943.1(TCF7L2):​c.1269+1360A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 152,258 control chromosomes in the GnomAD database, including 2,183 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 2183 hom., cov: 33)

Consequence

TCF7L2
NM_001367943.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.158

Publications

4 publications found
Variant links:
Genes affected
TCF7L2 (HGNC:11641): (transcription factor 7 like 2) This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]
TCF7L2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P
  • intellectual disability
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • congenital glaucoma
    Inheritance: Unknown Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001367943.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.221 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001367943.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TCF7L2
NM_001367943.1
MANE Select
c.1269+1360A>T
intron
N/ANP_001354872.1Q9NQB0-1
TCF7L2
NM_001146274.2
c.1269+1360A>T
intron
N/ANP_001139746.1Q9NQB0-7
TCF7L2
NM_030756.5
c.1200+1360A>T
intron
N/ANP_110383.2Q9NQB0-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TCF7L2
ENST00000355995.9
TSL:1 MANE Select
c.1269+1360A>T
intron
N/AENSP00000348274.4Q9NQB0-1
TCF7L2
ENST00000627217.3
TSL:1
c.1269+1360A>T
intron
N/AENSP00000486891.1Q9NQB0-7
TCF7L2
ENST00000369397.8
TSL:1
c.1200+1360A>T
intron
N/AENSP00000358404.4Q9NQB0-8

Frequencies

GnomAD3 genomes
AF:
0.145
AC:
22017
AN:
152140
Hom.:
2179
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0427
Gnomad AMI
AF:
0.133
Gnomad AMR
AF:
0.227
Gnomad ASJ
AF:
0.0795
Gnomad EAS
AF:
0.0578
Gnomad SAS
AF:
0.0780
Gnomad FIN
AF:
0.230
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.191
Gnomad OTH
AF:
0.140
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.145
AC:
22019
AN:
152258
Hom.:
2183
Cov.:
33
AF XY:
0.145
AC XY:
10791
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0426
AC:
1771
AN:
41570
American (AMR)
AF:
0.227
AC:
3475
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0795
AC:
276
AN:
3470
East Asian (EAS)
AF:
0.0577
AC:
299
AN:
5178
South Asian (SAS)
AF:
0.0781
AC:
377
AN:
4828
European-Finnish (FIN)
AF:
0.230
AC:
2437
AN:
10590
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.190
AC:
12952
AN:
68002
Other (OTH)
AF:
0.137
AC:
290
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
949
1897
2846
3794
4743
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.166
Hom.:
309
Bravo
AF:
0.144
Asia WGS
AF:
0.0600
AC:
209
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.8
DANN
Benign
0.60
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10509969;
hg19: chr10-114913559;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.